Skip to main content
Scott Shively

Scott Shively

CEO, Bexion Pharmaceuticals
United States
Scott Shively is an experienced Founder, CEO and CCO in the US and international biopharma markets. He previously served as CEO and Co-founder of Neumentum, Inc., a private clinical development stage company focused in the Pain and CNS therapeutic areas. His career spans from leading global commercial efforts for Pfizer in the Pain and CNS areas to C-suite leadership roles in specialty growth companies such as Alpharma, Zogenix and Depomed. Scott has extensive experience in product commercialization and launch, building and leading multifunctional teams, M&As and business development and fundraising, and has been involved in successful exits for several small to mid-sized biopharma companies.